Exhaled nitric oxide in paediatric asthma

R Ratnawati1, P S Thomas

  • 1Faculte of Medicine, UNSW, Australia.

Chronic Respiratory Disease
|November 12, 2005
PubMed

Insights

Monitoring airway inflammation in pediatric asthma is crucial. Exhaled nitric oxide offers a promising, non-invasive method for assessing asthma control in children, unlike traditional, invasive techniques.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Biomarker Research

Background:

  • Assessing airway function in young children with asthma is challenging and provides only a snapshot of disease status.
  • Traditional methods for evaluating asthmatic inflammation are often invasive and impractical for pediatric use.
  • There is a growing need for reliable, non-invasive methods to monitor airway inflammation and long-term disease activity in pediatric asthma.

Purpose of the Study:

  • To review the utility of exhaled nitric oxide as a marker of airway inflammation in pediatric asthma.
  • To compare exhaled nitric oxide with other established markers of asthma control.
  • To evaluate the potential of exhaled nitric oxide as a non-invasive tool for managing pediatric asthma.

Main Methods:

  • Literature review of studies assessing airway inflammation in pediatric asthma.
  • Comparison of exhaled nitric oxide measurements with other established inflammatory markers.
  • Analysis of the feasibility and efficacy of non-invasive monitoring techniques.

Main Results:

  • Exhaled nitric oxide is discussed as a potential biomarker for airway inflammation in asthma.
  • The review compares exhaled nitric oxide with other recognized markers for asthma assessment.
  • Non-invasive methods are highlighted as essential for pediatric populations.

Conclusions:

  • Exhaled nitric oxide shows potential as a non-invasive marker for assessing airway inflammation in pediatric asthma.
  • This method may offer a more comprehensive, longer-term view of disease activity compared to functional tests.
  • Further research supports exhaled nitric oxide as a valuable tool for pediatric asthma management.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...